非凋亡调节性细胞死亡基因对肺腺癌预后的预测价值及其生物学功能

李浩令; 王俊贤; 戴恒文; 刘俊杰; 刘子扬; 邹明远; 张雷; 王文锐

doi:10.24920/004222

Your Location：

Home >

Browse articles >

非凋亡调节性细胞死亡基因对肺腺癌预后的预测价值及其生物学功能

中国医学科学杂志（英文版） 2023年38卷第3期页码：178-190

论著 | Updated：2024-11-26

- 非凋亡调节性细胞死亡基因对肺腺癌预后的预测价值及其生物学功能
- Affiliations：
  
  1. 1Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu, Anhui 233030, China
  2. 2Department of Clinical Medicine, Bengbu Medical College, Bengbu, Anhui 233030, China
  3. 3Department of Life Sciences, Bengbu Medical College, Bengbu, Anhui 233030, China
  4. 4Department of Thoracic Surgery, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233030, China
- Author bio：
  
  * 王文锐,E-mail: wenrui-wang1983@163.com。
- Funds：
  
  安徽省自然科学基金(2108085MH294)
- DOI：10.24920/004222
  中图分类号：
- 收稿日期：2023-03-15，
  
  录用日期：2023-7-10，
  
  网络出版日期：2023-08-25，
  
  纸质出版日期：2023-09-30
- Accepted：
Scan QR Code
李浩令, 王俊贤, 戴恒文, 等. 非凋亡调节性细胞死亡基因对肺腺癌预后的预测价值及其生物学功能[J]. 中国医学科学杂志（英文版）, 2023,38(3):178-190.

Hao-Ling Li, Jun-Xian Wang, Heng-Wen Dai, et al. Prognostic Prediction Value and Biological Functions of Non-Apoptotic Regulated Cell Death Genes in Lung Adenocarcinoma[J]. Chinese medical sciences journal, 2023, 38(3): 178-190.
李浩令, 王俊贤, 戴恒文, 等. 非凋亡调节性细胞死亡基因对肺腺癌预后的预测价值及其生物学功能[J]. 中国医学科学杂志（英文版）, 2023,38(3):178-190. DOI： 10.24920/004222.

Hao-Ling Li, Jun-Xian Wang, Heng-Wen Dai, et al. Prognostic Prediction Value and Biological Functions of Non-Apoptotic Regulated Cell Death Genes in Lung Adenocarcinoma[J]. Chinese medical sciences journal, 2023, 38(3): 178-190. DOI： 10.24920/004222.

摘要

目的

探究非凋亡调节性细胞死亡基因（non-apoptotic regulatory cell death genes，NARCDs）预测肺腺癌预后的价值及其潜在生物学功能。

方法

我们下载癌症基因组图谱（The Cancer Genome Atla，TCGA）及基因表达综合（Gene Expression Omnibus，GEO）数据库中肺腺癌的转录组数据。使用R软件分析在肺腺癌组织和正常组织之间存在差异表达的NARCDs。采用单变量Cox分析和LASSO-Cox回归分析构建NARCDs预后模型。采用生存分析曲线、受试者工作特征曲线、单因素和多因素Cox回归分析评估NARCDs预后模型对肺腺癌预后的预测能力。采用GSVA、GO和KEGG分析NARCDs预后模型的功能富集情况。此外，我们分析了高、低NARCDs评分组间的肿瘤突变负担、肿瘤微环境、肿瘤免疫功能障碍与排斥（Tumor Immune Dysfunction and Exclusion，TIDE）评分和化疗药物敏感性的差异。最后，使用STRING和Cytoscape软件构建NARCDs与免疫相关基因的蛋白-蛋白相互作用网络。

结果

我们确定了34个与预后相关的差异表达NARCDs，其中16个基因（

ATIC

、

AURKA

、

CA9

、

ITGB4

、

DDIT4

、

CDK5R1

、

CAV1

、

RRM2

、

GAPDH

、

SRXN1

、

NLRC4

、

GLS2

、

ADRB2

、

CX3CL1

、

GDF15

和

ADRA1A

）被用于构建NARCDs预后模型。NARCDs风险评分是肺腺癌的独立预后因素（

0.001）。功能分析显示：高NARCDs评分组与低

NARCDs

评分组间在错配修复、p53信号通路和细胞周期方面存在显著差异（

0.05）。低NARCD评分组的肿瘤突变负荷较低，免疫评分及TIDE评分较高，对药物的敏感性较低（

0.05）。此外，蛋白-蛋白相互作用网络的10个关键基因（

CXCL5

、

TLR4

、

JUN

、

IL6

、

CCL2

、

CXCL2

、

ILA

、

IFNG

、

IL33

和

GAPDH

）均为免疫相关基因。

结论

基于16个基因构建的NARCDs预后模型是肺腺癌的独立预后因素，其能有效预测患者预后，并为临床治疗提供帮助。

Abstract

Objective

To explore the potential biological functions and prognostic prediction values of non-apoptotic regulated cell death genes (NARCDs) in lung adenocarcinoma.

Methods

Transcriptome data of lung adenocarcinoma were downloaded from The Cancer Genome Atlas and Gene Expression Omnibus databases. We identified differentially expressed NARCDs between lung adenocarcinoma tissues and normal tissues with R software. NARCDs signature was constructed with univariate Cox regression analysis and the least absolute shrinkage and selection operator Cox regression. The prognostic predictive capacity of NARCDs signature was assessed by Kaplan-Meier survival curve

receiver operating characteristic curve

and univariate and multivariate Cox regression analyses. Functional enrichment of NARCDs signature was analyzed with gene set variation analysis

Gene Ontology

and Kyoto Encyclopedia of Genes and Genomes. In addition

differences in tumor mutational burden

tumor microenvironment

tumor immune dysfunction and exclusion score

and chemotherapeutic drug sensitivity were analyzed between the high and low NARCDs score groups. Finally

a protein-protein interaction network of NARCDs and immune-related genes was constructed by STRING and Cytoscape software.

Results

We identified 34 differentially expressed NARCDs associated with the prognosis

of which 16 genes (

ATIC

AURKA

CA9

ITGB4

DDIT4

CDK5R1

CAV1

RRM2

GAPDH

SRXN1

NLRC4

GLS2

ADRB2

CX3CL1

GDF15

and

ADRA1A

) were selected to construct a NARCDs signature. NARCDs signature was identified as an independent prognostic factor (

0.001). Functional analysis showed that there were significant differences in mismatch repair

p53 signaling pathway

and cell cycle between the high NARCDs score group and low NARCDs score group (all

0.05). The NARCDs low score group had lower tumor mutational burden

higher immune score

higher tumor immune dysfunction and exclusion score

and lower drug sensitivity (all

0.05). In addition

the 10 hub genes (

CXCL5

TLR4

JUN

IL6

CCL2

CXCL2

ILA

IFNG

IL33

and

GAPDH

) in protein-protein interaction network of NARCDs and immune-related genes were all immune-related genes.

Conclusion

The NARCDs prognostic signature based on the above 16 genes is an independent prognostic factor

which can effectively predict the clinical prognosis of patients of lung adenocarcinoma and provide help for clinical treatment.

关键词

Keywords

references

Herbst RS , Morgensztern D , Boshoff C . The biology and management of non-small cell lung cancer . Nature 2018 ; 553 ( 7689 ): 446 - 54 . doi: 10.1038/nature25183 https://dx.doi.org/10.1038/nature25183 .

Miller K D , Nogueira L , Mariotto AB , et al . Cancer treatment and survivorship statistics, 2019 . CA Cancer J Clin 2019 ; 69 ( 5 ): 363 - 85 . doi: 10.3322/caac.21565 https://dx.doi.org/10.3322/caac.21565 . https://acsjournals.onlinelibrary.wiley.com/toc/15424863/69/5 https://acsjournals.onlinelibrary.wiley.com/toc/15424863/69/5

Gao W , Wang X , Zhou Y , et al . Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy . Signal Transduct Target Ther 2022 ; 7 ( 1 ): 196 . doi: 10.1038/s41392-022-01046-3 https://dx.doi.org/10.1038/s41392-022-01046-3 .

Liu J , Sun M , Sun Y , et al . TMEM189 promotes breast cancer through inhibition of autophagy-regulated ferroptosis . Biochem Biophys Res Commun 2022 ; 622 : 37 - 44 . doi: 10.1016/j.bbrc.2022.06.024 https://dx.doi.org/10.1016/j.bbrc.2022.06.024 . https://linkinghub.elsevier.com/retrieve/pii/S0006291X22008658 https://linkinghub.elsevier.com/retrieve/pii/S0006291X22008658

Xie Y , Zhao Y , Shi L , et al . Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer . J Clin Invest 2020 ; 130 ( 4 ): 2111 - 28 . doi: 10.1172/jci133264 https://dx.doi.org/10.1172/jci133264 .

Carleton G , Lum JJ . Autophagy metabolically suppresses CD8(+) T cell antitumor immunity . Autophagy 2019 ; 15 ( 9 ): 1648 - 9 . doi: 10.1080/15548627.2019.1628545 https://dx.doi.org/10.1080/15548627.2019.1628545 .

Snyder AG , Hubbard NW , Messmer MN , et al . Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK 3 potentiates antitumor immunity . Sci Immunol 2019 ; 2019 ; 4 ( 36 ): eaaw2004 . doi: 10.1126/sciimmunol.aaw2004 https://dx.doi.org/10.1126/sciimmunol.aaw2004 . https://www.science.org/doi/10.1126/sciimmunol.aaw2004 https://www.science.org/doi/10.1126/sciimmunol.aaw2004

Wang Q , Wang Y , Ding J , et al . A bioorthogonal system reveals antitumour immune function of pyroptosis . Nature 2020 ; 579 ( 7799 ): 421 - 6 . doi: 10.1038/s41586-020-2079-1 https://dx.doi.org/10.1038/s41586-020-2079-1 .

Xu C , Sun S , Johnson T , et al . The glutathione peroxidase Gpx 4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity . Cell Rep 2021 ; 35 ( 11 ): 109235 . doi: 10.1016/j.celrep.2021.109235 https://dx.doi.org/10.1016/j.celrep.2021.109235 . https://linkinghub.elsevier.com/retrieve/pii/S2211124721005945 https://linkinghub.elsevier.com/retrieve/pii/S2211124721005945

Fang Q , Chen H . Development of a novel autophagy-related prognostic signature and nomogram for hepatocellular carcinoma . Front Oncol 2020 ; 10 : 591356 . doi: 10.3389/fonc.2020.591356 https://dx.doi.org/10.3389/fonc.2020.591356 . https://www.frontiersin.org/articles/10.3389/fonc.2020.591356/full https://www.frontiersin.org/articles/10.3389/fonc.2020.591356/full

Xu D , Ji Z , Qiang L . Molecular characteristics, clinical implication, and cancer immunity interactions of pyroptosis-related genes in breast cancer . Front Med (Lausanne) 2021 ; 8 : 702638 . doi: 10.3389/fmed.2021.702638 https://dx.doi.org/10.3389/fmed.2021.702638 .

Zhang X , Yang Q . A pyroptosis-related gene panel in prognosis prediction and immune microenvironment of human endometrial cancer . Front Cell Dev Biol 2021 ; 9 : 705828 . doi: 10.3389/fcell.2021.705828 https://dx.doi.org/10.3389/fcell.2021.705828 . https://www.frontiersin.org/articles/10.3389/fcell.2021.705828/full https://www.frontiersin.org/articles/10.3389/fcell.2021.705828/full

Xing M , Li J . Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma . BMC Bioinformatics 2022 ; 23 ( 1 ): 177 . doi: 10.1186/s12859-022-04726-7 https://dx.doi.org/10.1186/s12859-022-04726-7 .

Zhang Z , Hu X , Qiu D , et al . Development and validation of a necroptosis-related prognostic model in head and neck squamous cell carcinoma . J Oncol 2022 ; 2022 : 8402568 . doi: 10.1155/2022/8402568 https://dx.doi.org/10.1155/2022/8402568 .

Hänzelmann S , Castelo R , Guinney J . GSVA: gene set variation analysis for microarray and RNA-seq data . BMC Bioinformatics 2013 ; 14 : 7 . doi: 10.1186/1471-2105-14-7 https://dx.doi.org/10.1186/1471-2105-14-7 .

Yoshihara K , Shahmoradgoli M , Martínez E , et al . Inferring tumour purity and stromal and immune cell admixture from expression data . Nat Commun 2013 ; 4 : 2612 . doi: 10.1038/ncomms3612 https://dx.doi.org/10.1038/ncomms3612 .

Jiang P , Gu S , Pan D , et al . Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response . Nat Med 2018 ; 24 ( 10 ): 1550 - 8 . doi: 10.1038/s41591-018-0136-1 https://dx.doi.org/10.1038/s41591-018-0136-1 .

Yang W , Soares J , Greninger P , et al . Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells . Nucleic Acids Res 2013 ; 41 : D955 - 61 . doi: 10.1093/nar/gks1111 https://dx.doi.org/10.1093/nar/gks1111 . http://academic.oup.com/nar/article/41/D1/D955/1059448/Genomics-of-Drug-Sensitivity-in-Cancer-GDSC-a http://academic.oup.com/nar/article/41/D1/D955/1059448/Genomics-of-Drug-Sensitivity-in-Cancer-GDSC-a

von Mering C , Huynen M , Jaeggi D , et al . STRING: a database of predicted functional associations between proteins . Nucleic Acids Res 2003 ; 31 ( 1 ): 258 - 61 . doi: 10.1093/nar/gkg034 https://dx.doi.org/10.1093/nar/gkg034 .

Chin CH , Chen SH , Wu HH , et al . cytoHubba: identifying hub objects and sub-networks from complex interactome . BMC Syst Biol 2014 ; 8 Suppl 4 ( Suppl 4 ): S11 . doi: 10.1186/1752-0509-8-s4-s11 https://dx.doi.org/10.1186/1752-0509-8-s4-s11 .

Han H , Yang C , Ma J , et al . N(7)-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis . Nat Commun 2022 ; 13 ( 1 ): 1478 . doi: 10.1038/s41467-022-29125-7 https://dx.doi.org/10.1038/s41467-022-29125-7 .

Lan H , Liu Y , Liu J , et al . Tumor-associated macrophages promote oxaliplatin resistance via METTL3-mediated m(6)A of TRAF5 and necroptosis in colorectal cancer . Mol Pharm 2021 ; 18 ( 3 ): 1026 - 37 . doi: 10.1021/acs.molpharmaceut.0c00961 https://dx.doi.org/10.1021/acs.molpharmaceut.0c00961 . https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.0c00961 https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.0c00961

Xu Y , Lv D , Yan C , et al. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m(6)A modification . Cancer Cell Int 2022 ; 22 ( 1 ): 11 . doi: 10.1186/s12935-021-02433-6 https://dx.doi.org/10.1186/s12935-021-02433-6 .

Li N , Wang J , Zhan X . Identification of immune-related gene signatures in lung adenocarcinoma and lung squamous cell carcinoma . Front Immunol 2021 ; 12 : 752643 . doi: 10.3389/fimmu.2021.752643 https://dx.doi.org/10.3389/fimmu.2021.752643 . https://www.frontiersin.org/articles/10.3389/fimmu.2021.752643/full https://www.frontiersin.org/articles/10.3389/fimmu.2021.752643/full

Wu X , Zhu J , Liu W , et al . A novel prognostic and predictive signature for lung adenocarcinoma derived from combined hypoxia and infiltrating immune cell-related genes in TCGA patients . Int J Gen Med 2021 ; 14 : 10467 - 81 . doi: 10.2147/ijgm.S342107 https://dx.doi.org/10.2147/ijgm.S342107 .

Niu N , Zeng J , Ke X , et al . ATIC facilitates cell growth and migration by upregulating Myc expression in lung adenocarcinoma . Oncol Lett 2022 ; 23 ( 4 ): 131 . doi: 10.3892/ol.2022.13251 https://dx.doi.org/10.3892/ol.2022.13251 .

Li Z , Zhang Y , Zhou Y , et al . Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway . Sci Rep 2021 ; 11 ( 1 ): 23681 . doi: 10.1038/s41598-021-03166-2 https://dx.doi.org/10.1038/s41598-021-03166-2 .

Zhang X , Liu X , Cui W , et al . Sohlh2 alleviates malignancy of EOC cells under hypoxia via inhibiting the HIF1α/CA9 signaling pathway . Biol Chem 2020 ; 401 ( 2 ): 263 - 71 . doi: 10.1515/hsz-2019-0119 https://dx.doi.org/10.1515/hsz-2019-0119 . https://www.degruyter.com/document/doi/10.1515/hsz-2019-0119/html https://www.degruyter.com/document/doi/10.1515/hsz-2019-0119/html

Gan L , Meng J , Xu M , et al . Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer . Oncogene 2018 ; 37 ( 6 ): 744 - 55 . doi: 10.1038/onc.2017.363 https://dx.doi.org/10.1038/onc.2017.363 .

Fan CC , Cheng WC , Huang YC , et al . EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma . Sci Rep 2017 ; 7 ( 1 ): 14617 . doi: 10.1038/s41598-017-15186-y https://dx.doi.org/10.1038/s41598-017-15186-y .

Jiang X , Li Y , Zhang N , et al . RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma . Cell Biosci 2021 ; 11 ( 1 ): 74 . doi: 10.1186/s13578-021-00586-5 https://dx.doi.org/10.1186/s13578-021-00586-5 .

Peng J , Li W , Tan N , et al. USP47 stabilizes BACH1 to promote the Warburg effect and non-small cell lung cancer development via stimulating Hk2 and Gapdh transcription . Am J Cancer Res 2022 ; 12 ( 1 ): 91 - 107 .

Lv X , Yu H , Zhang Q , et al . SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling . J Cell Mol Med 2020 ; 24 ( 18 ): 10714 - 29 . doi: 10.1111/jcmm.15693 https://dx.doi.org/10.1111/jcmm.15693 . https://onlinelibrary.wiley.com/toc/15824934/24/18 https://onlinelibrary.wiley.com/toc/15824934/24/18

Yu X , Liu W , Chen S , et al . Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity . J Immunother Cancer 2021 ; 9 ( 1 ): e001595 . doi: 10.1136/jitc-2020-001595 https://dx.doi.org/10.1136/jitc-2020-001595 . https://jitc.bmj.com/lookup/doi/10.1136/jitc-2020-001595 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2020-001595

Suzuki S , Venkatesh D , Kanda H , et al. GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma . Cancer Res 2022 ; 82 ( 18 ): 3209 - 22 . doi: 10.1158/0008-5472.Can-21-3914 https://dx.doi.org/10.1158/0008-5472.Can-21-3914 .

Lu T , Zheng C , Fan Z . Cardamonin suppressed the migration, invasion, epithelial mesenchymal transition (EMT) and lung metastasis of colorectal cancer cells by down-regulating ADRB2 expression . Pharm Biol 2022 ; 60 ( 1 ): 1011 - 21 . doi: 10.1080/13880209.2022.2069823 https://dx.doi.org/10.1080/13880209.2022.2069823 .

Tang W , Jia P , Zuo L , et al . Suppression of CX3CL 1 by miR-497-5p inhibits cell growth and invasion through inactivating the ERK/AKT pathway in NSCLC cells . Cell Cycle 2022 ; 21 ( 16 ): 1697 - 709 . doi: 10.1080/15384101.2022.2067438 https://dx.doi.org/10.1080/15384101.2022.2067438 . https://www.tandfonline.com/doi/full/10.1080/15384101.2022.2067438 https://www.tandfonline.com/doi/full/10.1080/15384101.2022.2067438

Duan L , Pang HL , Chen WJ , et al . The role of GDF 15 in bone metastasis of lung adenocarcinoma cells . Oncol Rep 2019 ; 41 ( 4 ): 2379 - 88 . doi: 10.3892/or.2019.7024 https://dx.doi.org/10.3892/or.2019.7024 .

Zhao H , Xu Y , Xie Y , et al . m6A regulators are differently expressed and correlated with immune response of esophageal cancer . Front Cell Dev Biol 2021 ; 9 : 650023 . doi: 10.3389/fcell.2021.650023 https://dx.doi.org/10.3389/fcell.2021.650023 . https://www.frontiersin.org/articles/10.3389/fcell.2021.650023/full https://www.frontiersin.org/articles/10.3389/fcell.2021.650023/full

Demelash A , Rudrabhatla P , Pant HC , et al . Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway . Mol Biol Cell 2012 ; 23 ( 15 ): 2856 - 66 . doi: 10.1091/mbc.E10-12-1010 https://dx.doi.org/10.1091/mbc.E10-12-1010 .

Du F , Sun L , Chu Y , et al . DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways . Cancer Commun (Lond) 2018 ; 38 ( 1 ): 45 . doi: 10.1186/s40880-018-0315-y https://dx.doi.org/10.1186/s40880-018-0315-y .

Nakae S , Suto H , Iikura M , et al . Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF . J Immunol 2006 ; 176 ( 4 ): 2238 - 48 . doi: 10.4049/jimmunol.176.4.2238 https://dx.doi.org/10.4049/jimmunol.176.4.2238 .

Lorente E , García R , López D . Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells . J Biol Chem 2011 ; 286 ( 44 ): 38054 - 9 . doi: 10.1074/jbc.M111.281808 https://dx.doi.org/10.1074/jbc.M111.281808 .

Ikeda H , Old LJ , Schreiber RD . The roles of IFN gamma in protection against tumor development and cancer immunoediting . Cytokine Growth Factor Rev 2002 ; 13 ( 2 ): 95 - 109 . doi: 10.1016/s1359-6101(01)00038-7 https://dx.doi.org/10.1016/s1359-6101(01)00038-7 . https://linkinghub.elsevier.com/retrieve/pii/S1359610101000387 https://linkinghub.elsevier.com/retrieve/pii/S1359610101000387

Vatner RE , Janssen EM . STING, DCs and the link between innate and adaptive tumor immunity . Mol Immunol 2019 ; 110 : 13 - 23 . doi: 10.1016/j.molimm.2017.12.001 https://dx.doi.org/10.1016/j.molimm.2017.12.001 .

Kirtonia A , Sethi G , Garg M . The multifaceted role of reactive oxygen species in tumorigenesis . Cell Mol Life Sci 2020 ; 77 ( 22 ): 4459 - 83 . doi: 10.1007/s00018-020-03536-5 https://dx.doi.org/10.1007/s00018-020-03536-5 .

Stenzinger A , Allen JD , Maas J , et al . Tumor mutational burden standardization initiatives: recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions . Genes Chromosomes Cancer 2019 ; 58 ( 8 ): 578 - 88 . doi: 10.1002/gcc.22733 https://dx.doi.org/10.1002/gcc.22733 . https://onlinelibrary.wiley.com/toc/10982264/58/8 https://onlinelibrary.wiley.com/toc/10982264/58/8

Xu J , Zhang Y , Jia R , et al . Anti-PD-1 antibody SHR-1210 combined with apatinib for advanced hepatocellular carcinoma, gastric, or esophagogastric junction cancer: an open-label, dose escalation and expansion study . Clin Cancer Res 2019 ; 25 ( 2 ): 515 - 23 . doi: 10.1158/1078-0432.Ccr-18-2484 https://dx.doi.org/10.1158/1078-0432.Ccr-18-2484 .

Ning XH , Li NY , Qi YY , et al . Identification of a hypoxia-related gene model for predicting the prognosis and formulating the treatment strategies in kidney renal clear cell carcinoma . Front Oncol 2021 ; 11 : 806264 . doi: 10.3389/fonc.2021.806264 https://dx.doi.org/10.3389/fonc.2021.806264 . https://www.frontiersin.org/articles/10.3389/fonc.2021.806264/full https://www.frontiersin.org/articles/10.3389/fonc.2021.806264/full

Zhou G , Liu Z , Myers JN . TP53 mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment response . J Cell Biochem 2016 ; 117 ( 12 ): 2682 - 92 . doi: 10.1002/jcb.25592 https://dx.doi.org/10.1002/jcb.25592 .

Canale M , Andrikou K , Priano I , et al . The role of TP 53 mutations in EGFR-mutated non-small-cell lung cancer: clinical significance and implications for therapy . Cancers (Basel) 2022 ; 14 ( 5 ): 1143 . doi: 10.3390/cancers14051143 https://dx.doi.org/10.3390/cancers14051143 . https://www.mdpi.com/2072-6694/14/5/1143 https://www.mdpi.com/2072-6694/14/5/1143

浏览量

737

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

关联资源

Influence of GPRC5A-Regulated ABCB1 Expression on Lung Adenocarcinoma Proliferation

Identifying and Validating a Novel miRNA-mRNA Regulatory Network Associated with Prognosis in Lung Adenocarcinoma